About Us

Artificiële Intelligentie & Recht - AI and the Law

AIRecht is the legal platform for organizations building with AI, data and quantum technology — and determined to scale with confidence. We translate European technology regulation, North American policy and Silicon Valley research into decisions you can execute: EU AI Act readiness, IP strategy, export controls and dual-use governance. Founder Mauritz Kop established the Stanford Center for Responsible Quantum Technology (founding director, 2023–2025) and is a Senior Fellow at the CIGI think tank; AIRecht works at the intersection of academia, policy and industry.

2026 so far

• NATO Strategic Communications Centre of Excellence engaged Mauritz Kop as a subject-matter expert for the Riga workshop "The Integrity of Reality and Cognitive Sovereignty" (June 2026).
• G7: CIGI opinion "From Kananaskis to Évian: Will the G7 Govern Quantum?" published around the Évian summit (June 2026).
• Harvard Law School (Petrie-Flom): "Hippocratic Quantum" (Feb 2026) · Vanderbilt JETLaw: "Quantum Needs a Smarter Legal Control Plane" (2026) · CIGI Policy Brief 222 (Jan 2026) · CIGI Quantum Nexus Emerging Scholars Program (June 2026).
• Earlier: Columbia Journal of European Law, "Towards a European Quantum Act" (2025) · Science (2025) · Nature Physics, "A Call for Responsible Quantum Technology" with Urs Gasser and I. Glenn Cohen (2024).
• His team's work has been covered by Forbes, Fortune and MIT Sloan.

Readiness & Regulatory Roadmap

We help our clients prepare for the obligations of the EU AI Act, the Data Governance Act and the GDPR — often a cross-disciplinary effort — and we conduct due diligence investigations for mergers & acquisitions. We advise organizations from tech startups to globally operating multinationals. For questions on EU AI Act obligations — risk classification, your role in the AI value chain, gap analysis and technical documentation — we deliver a grounded readiness assessment and a realistic roadmap toward the phased deadlines — including the Digital Omnibus (provisional agreement, May 2026), which is expected to move the high-risk obligations of Annex III to 2 December 2027 and Annex I to 2 August 2028; until formal adoption, the original dates formally remain in force.

Publications about AI and Quantum in Healthcare:

We publish at Stanford, Harvard, Yale, and on the website of the European Commission about AI and Quantum Technology in the life sciences and healthcare sector, and beyond. See for example:

1. A Brief Quantum Medicine Policy Guide https://blog.petrieflom.law.harvard.edu/2024/12/06/a-brief-quantum-medicine-policy-guide/

2. How Quantum Technologies May Be Integrated Into Healthcare, What Regulators Should Consider https://law.stanford.edu/publications/how-quantum-technologies-may-be-integrated-into-healthcare-what-regulators-should-consider/

3. EU and US Regulatory Challenges Facing AI Health Care Innovator Firms https://blog.petrieflom.law.harvard.edu/2024/04/04/eu-and-us-regulatory-challenges-facing-ai-health-care-innovator-firms/

4. Regulating Quantum & AI in Healthcare: A Brief Policy Guide https://futurium.ec.europa.eu/en/european-ai-alliance/document/regulating-quantum-ai-healthcare-brief-policy-guide

by Mauritz Kop, Suzan Slijpen, Katie Liu, Jin-Hee Lee, Constanze Albrecht & I. Glenn Cohen

Disruptive Innovation

Big technological advances always challenge legal doctrine. As legal pioneers in AI deployment and disruptive innovation policy making, our mission is to remove obstacles to trade, production and investment in robust, social and reliable AI — and to strategically maximize the quality of intellectual property on AI input and output in an ethically responsible, human-centric manner, respecting fundamental rights such as freedom of expression and privacy. AIRecht in the media, radio, television and newspapers.

Sector knowledge

Our team works in the nexus of AI & Law across the Pharmaceutical, eHealth, Medical Device, Food & Feed, Consumer Electronics, Energy, Transportation & Logistics, Automotive and Entertainment & Video Game industries — a holistic understanding of sector-specific rules, translated into contracts, readiness files and business strategy.

Three ways to work with us

1 · AI & ICT contract scan (self-service, today). Upload your AI, software or SaaS contract; the scan grades every clause Green · Amber · Red, detects what is missing, and returns a counter-proposal with ready-to-send replacement language. Fixed fee by size: €119 · €225 · €325 · €495 · €1,000 — fully online, no appointment. Not generic model output: a specialized process with a domain rubric, an audit trail and an upgrade path to specialist review. Start the contract scan →

2 · Readiness & red-flag scans (fixed scope, fixed fee). EU AI Act readiness: risk classification, value-chain role, gap analysis, and a realistic roadmap toward the amended deadlines.

3 · Strategic advice (selective). For boards and general counsel: IP portfolios, M&A due diligence, export controls, dual-use governance. Deliberately compact — a limited number of engagements per year, with priority for existing clients and referrals.

Legal team

mr. Mauritz Kop — founder. Twenty years of IP and technology law. Founding Director, Stanford Center for Responsible Quantum Technology (2023–2025); Stanford Law School TTLF Fellow; Senior Fellow, CIGI; guest professor, U.S. Air Force Academy. Advised the European Parliament on the Copyright Reform and the Digital Single Market; member of the Dutch Copyright Society (VvA), the European AI Alliance, CLAIRE, the Dutch AI Coalition, ECP and the World Economic Forum. Published by Nature Physics, Science and the journals of Stanford, Harvard, Yale and Columbia; commentary in NRC, NOS, RTL Nieuws and Al Jazeera. His team's work has been covered by Forbes, Fortune and MIT Sloan. Practice: Netherlands, Europe, US, Canada.

mr. Suzan Slijpen LL.M. — senior consultant. Pharmaceutical, food and biotech law; teaches European food & feed law, biotechnology and AI at university level; member of NVLR, the Vereniging Farma en Recht (VFenR) and the Dutch AI Coalition; frequently asked international conference speaker; winner of the prestigious Molengraaff Institute thesis prize (2015).

Intellectual property & life sciences

In pharmaceutical law we advise on traceability, Good Manufacturing Practices (GMP), permit requirements, product safety and liability, medicine packaging, quality standards and AI systems in healthcare. In intellectual property we cover patents, trade secrets, copyright on AI input and output, software licensing and data sharing — drafting and screening the international business contracts that carry them.

Legal Pioneers

Get in touch

We know that choosing a legal adviser is not a decision to take lightly. If your question starts with a contract or with AI Act readiness, start today with the contract scan or a readiness scan — fixed fee, immediate result, no appointment needed. Strategic matters can be submitted in writing via the dossier form; the practice is selective and we reach out when a matter fits — and we will tell you honestly if you don't need us.